Teradyne (TER.NASDAQ) AI OPINIONS & ADVISOR ANALYSIS
Read the selected AI Advisor’s complete report, scenarios and forecast. Select Consensus for its investment thesis and a preview of advisor weights. Eligible access unlocks all 14 advisor reports and comparisons.
Updated on 20 September 2026Deep analysis 20 September 2026
Russlan Ramdowar
Opus 5Universal Investor AI
The Polymath FrameworkModel rating
Partial Sell
5-Year Return Est.
+33.3%
Includes 0.08% annual net dividend contribution
Historical prices and published forecast
- Observed price
- Published advisor forecast
Quarterly Events ForecastPrice targets, total returns and complete scenario reasoning
Forecast prices in USD. Returns are cumulative from the forecast anchor. Swipe horizontally to read every column.
| Quarter | Forecast | Total return | Scenario |
|---|---|---|---|
| $349 | -6.0% | The late-October Q3 print delivers the guided sequential step-down to $1.2-1.3 billion with gross margin easing to 58-59%. A 5% ten-year yield punishes a 50x multiple into year-end positioning. | |
| $384 | +3.4% | Q4 results and the promised target-model reset arrive in late January. An upward-revised revenue and EPS ambition re-bases the denominator, converting valuation anxiety into a credible 2027 earnings bridge. | |
| $403 | +8.6% | First dual-vendor compute sockets convert while memory test holds near records on HBM4 qualification. Q1 2027 beats, and fab-light operating leverage lifts EPS faster than the multiple fades. | |
| $371 | -0.1% | AI-capex financing stress resurfaces as hyperscaler free cash flow deteriorates. Because ATE orders lag capex by two quarters, sentiment de-rates test equipment names well before bookings actually roll over. | |
| $397 | +6.9% | Orders prove more resilient than feared. Teradyne confirms merchant-GPU volume shipments and full-year growth, restoring the narrative; buybacks and index flows amplify a relief rally into year-end. | |
| $373 | +0.5% | Peak-cycle anxiety dominates. Initial 2028 guidance implies digestion after two years of accelerator test capacity additions, and the multiple compresses even while absolute earnings hold roughly flat. | |
| $358 | -3.6% | Digestion is confirmed: customers raise utilisation of installed testers instead of buying new ones. Revenue growth stalls, gross margin slips toward 58%, and the cyclical discount reasserts itself. | |
| $376 | +1.3% | Trough visibility arrives. Memory test re-accelerates on next-generation HBM, and an edge-inference silicon wave broadens the customer set beyond the three hyperscalers currently driving compute revenue. | |
| $391 | +5.3% | Policy easing lowers the discount rate applied to long-duration semicap earnings. Teradyne's net-cash balance sheet and a refreshed repurchase authorisation support a modest year-end re-rating. | |
| $403 | +8.5% | Full-year results confirm a shallow trough. ATE TAM tracks toward the upper end of the $12-14 billion frame, though share capture against Advantest remains stubbornly socket-by-socket. | |
| $383 | +3.1% | Export-control tightening and tariff friction on advanced test tools clip the addressable Asian customer base. Guidance is trimmed and a geopolitical risk premium widens across the semicap complex. | |
| $398 | +7.2% | Clarified licensing rules restore deferred order flow. Robotics, long an option rather than a driver, finally scales toward a double-digit revenue share on warehouse automation demand. | |
| $418 | +12.5% | A new process-node ramp at leading foundries reignites SoC test intensity. Growing installed-base service revenue cushions mix, and gross margin recovers above 59%, supporting earnings quality. | |
| $431 | +15.9% | Steady compounding without excitement. Earnings grow mid-teens while the multiple continues drifting toward the semicap average band, capping appreciation despite genuinely solid operational execution. | |
| $448 | +20.5% | Advanced packaging and co-packaged optics test emerge as a distinct revenue line, validating the MultiLane joint venture and widening the competitive moat against Advantest at full-system level. | |
| $430 | +15.7% | A mid-decade inventory correction in accelerator silicon trims orders. Teradyne's high fixed R&D base means decremental margins bite faster than consensus models assume, pressuring the shares. | |
| $451 | +21.5% | The correction proves shallow. Management reaffirms a structurally higher revenue floor and accelerates repurchases at a lower multiple, genuinely improving per-share economics for the first time this cycle. | |
| $465 | +25.2% | A mature-growth regime settles in. ATE TAM expansion decelerates toward transistor and bit growth, so returns track earnings rather than re-rating; dividend growth resumes as secondary support. | |
| $479 | +28.9% | Memory test share gains compound quietly while free cash flow conversion normalises above 20% of revenue, supporting a stable and deliberately unexciting valuation for a cyclical franchise. | |
| $493 | +32.8% | End state: a larger, more diversified test franchise trading at a mid-twenties multiple. Incremental shareholder returns now come from buybacks and steady AI-adjacent demand rather than re-rating. |
1. Investment Thesis — Base Case
The tension is simple: the boom is verified, the share-gain story is deferred, and the multiple has already been paid. Teradyne should earn roughly $8 per share in 2026 on a $5.0-5.2 billion run-rate, already brushing the $6 billion revenue contemplated by its own mature-TAM target model [15][16]. Earnings keep compounding as test intensity rises, but from 50.9x trailing against a 5% long bond, most of the next five years' fundamental progress funds multiple compression rather than shareholder return. Investors own a superb franchise at an unforgiving entry price.
- FY2026 run-rate near $5.1 billion revenue and about $8 EPS, versus $3.19 billion revenue in FY2025.
- Base case applies roughly 29x to mid-teens 2031 EPS, implying a share price near $490.
- That equals about $75 billion of equity value on roughly 152 million shares after continued repurchases.
2. Scenarios & Signals
2.1. Bull Case
The bull case activates if the Q4 2026 target-model reset lands far above $6 billion and merchant-GPU sockets convert faster than the CEO's "gradual" framing implies. A re-based denominator turns today's 50x into tomorrow's 25x without a price decline, inviting earnings-revision momentum into a 99.8% institutionally owned float. Add an HBM4 capacity wave and a robotics segment finally scaling, and both earnings and the multiple expand together, delivering returns far above the base path.
2.2. Bear Case
The bear case activates when AI capex financing tightens and digestion arrives simultaneously. Hyperscaler credit stress cuts accelerator orders; ATE bookings roll over two quarters later; Teradyne's fixed R&D base turns operating leverage into decremental leverage, and margins retreat toward the high-fifties. A stock owned almost entirely by institutions on an earnings-revision thesis then de-rates violently — history shows 2022-2023 revenue declines of roughly 15% annually. Buybacks executed above 50x compound the per-share damage.
2.3. Behavioral Alpha Signals
Sentiment, repricing cycle, crowd narrative, catalyst, and macro alignment.Expected Volatility Regime
Greed and Fear Index
Cycle Position
Price action and thesis reinforcement are feeding each other.
What does Media Tell? (Crowd Consensus)
The settled belief is that Teradyne has stopped being a cyclical and become an AI infrastructure annuity. Sell-side targets cluster between roughly $400 and $475 across aggregators, with Susquehanna at $550, while Baird's August downgrade on valuation was treated as noise. The anchoring bias is the 213% twelve-month advance itself: investors extrapolate 104% revenue growth, quietly ignoring that management guided second-half 2026 below the first half.
What Crowds Get Wrong? (Alpha/Value Gap)
The crowd overestimates these shares, though the overpricing is a matter of degree rather than delusion. The decisive overlooked evidence is arithmetic: at $371 the stock trades at 33.8x-39.1x management's own mature-TAM target EPS of $9.50-$11.00 [15][16] — a model that already assumes the ATE market grows 40-55% and Teradyne gains share. Buying that, plus buybacks executed above 50x trailing earnings, means investors are paying today for the fully realised bull case and receiving a 1.37% free-cash-flow yield against a 5% long bond.
When will Value Gap Repricing Happen? (Repricing Catalyst)
The Q4 2026 earnings call, around late January 2027, when management resets its target earnings model [3]. That is the only mechanism that can legitimise the multiple by re-basing the denominator. The first observable sign of repricing is whether the new revenue ambition exceeds $8 billion or anchors conservatively near $6-7 billion.
How is Asset Influenced by Macro Regime?
The macro wind is in its face on valuation and at its back on demand. A 4.998% ten-year yield and a Fed at 3.75%-4.00% compress precisely the long-duration, low-cash-return equity Teradyne has become at 50.9x. Meanwhile AI capex remains the one spending line immune to restrictive policy — until credit conditions reach the hyperscalers' financing plans.
3. Positive & Negative Factors, Risks & Opportunities
3.1. Base-Case Forces
Near-certain positive forces
Top Drivers / Tailwinds
Structural or operating forces that support this advisor thesis. These forces are treated as part of the base case (more than 60% probability of occurrence).
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| TEST Intensity Beats UNIT Growth | Sector And Industry | +55% | +90% | The engine is physics, not volume. At 2nm and with stacked HBM, defect surface and test time per die expand faster than wafer starts, so customers must buy more testers per chip shipped; memory test set a record $212 million in Q2 2026 [1][4]. Management and Advantest both frame the ATE TAM migrating from roughly $9 billion toward $12-14 billion [3][16], a multi-year, structurally sticky expansion. |
| Socket BY Socket DUAL Vendor Conversion | Competitive Positioning | +25% | +25% | Hyperscalers and merchant accelerator vendors will not tolerate single-source test. Smith described one compute customer in mature dual-vendor phase, one fast follower, one in qualification, with effects appearing from 2027 [4]. Teradyne shipped its first merchant GPU order and completed correlation at a second hyperscaler in early Q3 2026 [9]. Each qualified socket is a multi-year annuity of tester plus consumable and service revenue. |
| FAB Light Operating Leverage | Operational Efficiency | +20% | +30% | Teradyne outsources most manufacturing, so incremental revenue converts unusually well. Operating margin moved from 21.7% for FY2025 to 33.7% in Q2 2026 on roughly doubled revenue [10], with capex only around 7% of sales. That asymmetry means an ATE TAM at $12-14 billion produces earnings growth far above revenue growth, and it persists as long as volumes stay above the fixed R&D base. |
| Wafer TO Datacenter Product Widening | Innovation And Product | +15% | +12% | Teradyne is converting a tester franchise into a system-test franchise. The MultiLane joint venture targets high-speed I/O and datacenter interconnect test [15], LitePoint extended into UWB validation with STMicroelectronics, and the Technoprobe stake anchors the probe-card interface layer. Each adjacency raises content per AI rack tested and lengthens the revenue tail beyond capital equipment, defending gross margin in the 59-61% band management targets [15]. |
Near-certain negative forces
Top Frictions / Headwinds
Expected frictions that can slow, cap, or damage this advisor thesis. These forces are treated as part of the base case (more than 60% probability of occurrence).
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| FIVE Percent BOND Versus 14% Yield | Macroeconomic And Macrofinancial | -40% | -3.0% | The hardest arithmetic in the case. The Fed raised to 3.75%-4.00% effective 17 September 2026 with 2026/2027 median dots at 4.1%, and the US 10-year closed at 4.998%. Against that, TER offers a 1.37% TTM free-cash-flow yield at 50.9x trailing earnings and a 0.13% dividend. Long-duration equity with no cash return is exactly what a persistently restrictive real-rate regime de-rates first. |
| THE Digestion THAT Always Follows | Sector And Industry | -25% | -35% | ATE is a capital-equipment business with a memory. Revenue fell 14.8% in 2022 and 15.2% in 2023 after the last boom; management already guides second-half 2026 to 48-50% of the year and flagged compute order-timing softness [3][10]. Accelerator test capacity installed in 2025-2026 will be absorbed before it is replaced, so a one-to-two year digestion phase is near-certain within the horizon. |
| Advantest OWNS THE Merchant GPU | Competitive Positioning | -12% | -10% | The 600% compute growth is market expansion, not share capture. Third-party estimates put Advantest at 58-60% of ATE and dominant in merchant accelerators, with Teradyne stronger among vertically integrated customers [13][12]; these splits are unverified but directionally corroborated. Smith himself called the 2027 share shift "gradual... a socket-by-socket thing" [4]. Anyone paying $371 for rapid displacement is paying now for a nine-to-twelve-month qualification treadmill. |
| Testers ARE Licensable Chokepoints | Regulatory | -8.0% | -12% | High-end SoC and HBM testers sit precisely where export-control regimes bite. Replacement Section 301 duties across 60 economies and rare-earth shipment friction already raise cost, and ATE has historically been a licensing target for advanced-node customers. Teradyne's concentration in Taiwan-linked and Asian foundry customers converts any tightening into direct revenue deferral. No quantified exposure is disclosed, which is itself a monitoring gap. |
3.2. Risks & Opportunities
Plausible downside scenarios
Tail Risks
Less likely downside scenarios that could materially hurt the outcome if they occur.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| AI Financing Squeeze HITS Bookings | 35% | -45% | AI capex is funded by increasingly stretched balance sheets: Oracle posted negative $5 billion free cash flow against $664 billion of remaining performance obligations, OpenAI ruled out a 2026 IPO, and a 18 September 2026 antitrust complaint named the leading labs. A credit repricing in 2027-2028 would cut hyperscaler capex, reaching ATE order books within two quarters. With AI above 60% of revenue [5], earnings and the 50x multiple compress simultaneously. Below 50% because current demand signals remain firm. |
| Export Licence WALL ON Advanced TEST | 20% | -35% | A tightening of US or allied export controls covering leading-edge SoC and HBM test equipment, or a Taiwan-linked escalation disrupting foundry customers, would strand a meaningful slice of Teradyne's Asian revenue with little substitution available. The mechanism is immediate: shipments deferred, backlog reclassified, gross margin diluted by underutilised capacity. Most likely trigger window is 2027-2029 as AI chip nationalism hardens. It stays a minority scenario because testers sit downstream of the litho chokepoints regulators prioritise. |
Plausible upside scenarios
Tail Opportunities
Less likely upside scenarios that could materially improve the outcome if they occur.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Winning THE Accelerator Flagship | 25% | +45% | If a top merchant accelerator vendor converts Teradyne from qualification to primary-vendor status on a flagship GPU family during 2027-2028, the revenue step is not incremental but discontinuous: flagship programmes carry multi-hundred-million-dollar tester and interface content per ramp. That would confirm the duopoly is genuinely contestable and trigger both an earnings-revision cycle and multiple expansion. Probability stays below half because dual-vendor qualification is a four-phase, nine-to-twelve-month process the CEO explicitly refused to accelerate [4]. |
| THE Target Model Reset Bombshell | 40% | +30% | Management said it will update its target earnings model on the Q4 2026 call, around late January 2027, and remains confident of reaching it "at an accelerated pace" [3]. The old model assumed roughly $6 billion revenue and $9.50-$11.00 EPS at a $12-14 billion TAM [15][16]; FY2026 is already tracking $5.0-5.2 billion. A reset toward $8-9 billion and mid-to-high-teens EPS would re-base the denominator and legitimise today's multiple. It stays below 50% because management may anchor conservatively to a cycle-averaged TAM. |
5. References & Context
Search behavior, retained evidence, supplied context, and response token details.External web search was used. The retained search terms and consulted sources are shown below.
Context supplied to the model
Public-safe inputs retained with this immutable forecast publication.
- 01
Market data
inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1
- 02
Global context in this run
Used
- 03
Fundamental data in this run
Used
- 04
Global context
Standard global market and cross-asset context
- 05
Subject context
Equity-specific subject and market context
- 06
Task framework
Standard investment-forecast task guidelines
- 07
Advisor framework
Universal Investor The Polymath
- 08
Forecast output requested
Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)
Global context snapshot
2026 Year-to-Date Global Market and World-Events Context Through September 20
Download Archived SnapshotCoverage 2026-01-01 to 2026-09-20 · Knowledge cutoff 2026-09-20
January 1-September 20, 2026: monetary tightening, energy security, trade restrictions, AI financing and divergent growth; five leading market themes.
Fed raised rates to 3.75%-4.00%; ECB hike is in force and BOJ increase starts September 24. Markets through September 18, bitcoin through September 19.
| Top 3 Market Shifts From File | Date | Status |
|---|---|---|
| Renewed monetary tightening amid persistent inflation | 2026-01-30 | ACTIVE POLICY REGIME |
| Iran/Hormuz conflict and wider energy-security disruption | 2026-02-28 | ONGOING |
| Tariff legal reset and strategic supply restrictions | 2026-02-20 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
Fundamental context
Income statement
9 fieldsdepreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields
Balance sheet
12 fieldscash · commonStockSharesOutstanding · longTermDebt · netDebt · +8 more fields
Cash flow
5 fieldscapitalExpenditures · dividendsPaid · freeCashFlow · salePurchaseOfStock · +1 more field
annual: 2014-12-31–2025-12-31, 12 periods; quarterly: 2023-09-30–2026-06-30, 12 periods
Currencies cited: USD (quote USD; primary reporting USD; converted/valuation USD).
Search terms retained
- 1.Teradyne Q2 2026 results revenue guidance
- 2.Teradyne 2026 HBM memory test AI SoC test share Advantest
- 3.Teradyne stock September 2026 price target analysts
- 4.Teradyne Technoprobe stake robotics segment 2026 acquisition capital allocation
- 5.Teradyne 2027 consensus EPS estimate ATE market TAM outlook 2027
Sources retained for this advisor
- [1]Teradyne Reports Second Quarter 2026 Results :: Teradyne, Inc. (TER)investors.teradyne.com
- [2]Teradyne posts Q2 2026 revenue up 104% to $1.33B | TER 8-K Filingstocktitan.net
- [3]Earnings call transcript: Teradyne tops Q2 2026 estimates on AI demand By Investing.cominvesting.com
- [4][TER Q2 2026 Earnings Call] Teradyne Tops $1.3 Billion in Record Quarter as AI Demand Fuels 300% EPS Surge — BigGo Financefinance.biggo.com
- [5]Teradyne, Inc. (TER) Q2 FY2026 earnings call transcriptfinance.yahoo.com
- [6]Teradyne Reports First Quarter 2026 Results :: Teradyne, Inc. (TER)investors.teradyne.com
- [7]Teradyne Stock Is Up 400% and Analysts Are Still Calling for More Upside in 2026 | TIKR.comtikr.com
- [8]TERADYNE, INC - Form 10-Q - FY2026sec.gov
- [9]Teradyne posts transcript of Q2 2026 earnings callwebull.com
- [10]Teradyne Q2 2026 slides: AI drives record revenue, 104% growth By Investing.cominvesting.com
- [11]Teradyne ($TER) Deep Dive - by Jimmy Investorjimmysjournal.substack.com
- [12]Advantest Leading the AI Testing Wave: Earning the Title of the “ASML of the Test Industry”tspasemiconductor.substack.com
- [13]The Brains and the Limbs: A Deep-Dive into Teradyne’s (TER) AI-Driven Ascent | FinancialContentfinancialcontent.com
- [14]FinancialContent - The Brains and the Limbs: A Deep-Dive into Teradyne’s (TER) AI-Driven Ascentmarkets.financialcontent.com
- [15]Free Trialmarketbeat.com
- [16]Teradyne Stock: Analysts See More Upside in 2026 After Soaring 242% Last Year | TIKR.comtikr.com
- [17]seekingalpha.comseekingalpha.com
- [18]Earnings Estimates Rising for Teradyne (TER): Will It Gain?finance.yahoo.com
- [19]Teradyne Stock: You're Not Thinking About 2027 (NASDAQ:TER) | Seeking Alphaseekingalpha.com
- [20]Teradyne (NasdaqGS:TER) Stock Forecast & Analyst Predictions - Simply Wall Stsimplywall.st
- [21]Teradyne Inc. stock gains as analysts lift upside after strong rallyad-hoc-news.de
- [22]Teradyne Inc. stock gains as AI strategy and analyst targets support valuationad-hoc-news.de
- [23]Teradyne Inc. stock dips after recent slide while earnings and analyst targets support valuationad-hoc-news.de
- [24]Teradyne (TER) Stock Price & Overviewstockanalysis.com
- [25]__symbol__ Stock Quote Price and Forecast | CNNcnn.com
- [26]Teradyne (TER) Stock Forecast: Analyst Ratings, Predictions & Price Target 2026public.com
- [27]TERADYNE, INC - Form 10-K - FY2024sec.gov
- [28]TERADYNE, INC - Form 10-Q - FY2024sec.gov
- [29]Teradyne Drives Robotics Growth With AI: A Sign for More Upside?finance.yahoo.com
- [30]FinancialContent - The Gatekeeper of Silicon and Steel: A Deep Dive into Teradyne (TER) in 2026markets.financialcontent.com
Original published forecast
Inspect the original revision and sealed receipt when a public record is available. Integrity verification is separate from forecast accuracy.
A consensus thesis is not available for this publication.